Skip to main content
. 2022 Jan 6;19(1):22–32. doi: 10.1177/17407745211069153

Table 4.

Number of clinical trials in chronic diseases of interest by intervention types in Indigenous populations of Australia, Canada, New Zealand, and the United States.

Chronic condition Intervention Australia Canada New Zealand United States
Arthritis Combination a 1
Drug/biological 2
Total = 3 3
Cardiovascular disease Behavioral 2 7 2
Combination a 4 4 2
Device 1
Drug/biological 2 1 1
Other b 2 1
Procedure/screening 2 1
Total = 32 12 13 7
Dental/periodontal disease Behavioral 2 2 1
Combination a 1 1
Other b 2 1
Total = 10 5 1 2 2
Diabetes Behavioral 1 2 5 8
Combination a 1 2
Device 2
Drug/biological 2 1 2
Other b 1 1
Procedure/screening 1 1 1
Total = 31 6 5 9 11
Hypertension Behavioral 1 7
Device 1
Other b 1
Total = 10 1 1 8
Kidney disease Behavioral 1 2
Other b 2
Procedure/screening 1
Total = 6 1 1 4
Mental illness Behavioral 9 3 8 29
Combination a 1 2
Device 1 1
Drug/biological 2
Other b 3 1
Procedure/screening 1 1
Total = 62 17 3 11 31
Respiratory disease Behavioral 1 2
Combination a 1 3 2
Drug/biological 2 2
Other b 1
Procedure/screening 1 1
Total = 16 5 7 4

Bold italic values indicates the total number of clinical trial studies per chronic disease per country.

a

Combination: a mix of Behavioral, Lifestyle, Education, and Rehabilitation interventions.

b

Other: gardening, digital stories, lifestyle coaching, case management, Ma ka hana ka Ike, Hanapū Provider Toolbox.